LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Overview Fund Activity
Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

130 hedge funds and large institutions have $196M invested in Lumos Pharma, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 43 increasing their positions, 26 reducing their positions, and 25 closing their positions.

Holders
130
Holders Change
+4
Holders Change %
+3.17%
% of All Funds
2.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
43
Reduced
26
Closed
25
Calls
$6.83M
Puts
$3.24M
Net Calls
+$3.59M
Net Calls Change
-$6.72M

Top Buyers

1
GPP
1
Great Point Partners
Connecticut
$16.1M
2
Millennium Management
2
Millennium Management
New York
$19M
3
RG
3
Redmile Group
California
$17M
4
ACA
4
Avoro Capital Advisors
New York
$6.45M
5
BlackRock
5
BlackRock
New York
$18.8M

Top Sellers

1
O
1
OrbiMed
New York
$0
2
CCI
2
Columbus Circle Investors
$0
3
MWNA
3
Marshall Wace North America
New York
$0
4
PP
4
PDT Partners
New York
$0
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
NFA
151
Nationwide Fund Advisors
Ohio
– -$131K -1,426 Closed
OC
152
Oppenheimer & Co
New York
– -$114K -1,244 Closed
Capital Fund Management (CFM)
153
Capital Fund Management (CFM)
France
– -$108K -1,178 Closed
PCM
154
Prelude Capital Management
New York
– -$32K -344 Closed
3 4 5 6
7